Submit Your Feeds

Business News • PR NewsWire • Improved Outcomes for Patients Treated with Lantus® and Apidra® Regimen Compared with Sliding Scale Insulin

Improved Outcomes for Patients Treated with Lantus® and Apidra® Regimen Compared with Sliding Scale Insulin
Improved Outcomes for Patients Treated with Lantus® and Apidra® Regimen Compared with Sliding Scale Insulin

PARIS, June 25 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that results from the RAndomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients with Type 2 Diabetes Undergoing General Surgery (RABBIT-2 Surgery) found that treatment

View More : http://www.prnewswire.com/news-releases/improved-outcomes-for-patients-treated-with-lantus-and-apidra-regimen-compared-w...
Releted News by prnewswire
Improved Outcomes for Patients Treated with Lantus® and Apidra® Regimen Compared with Sliding Scale Insulin
Proper Power Receives Additional Endorsements on Thrust Resources
AllianceBernstein National Municipal Income Fund, Inc. Reports Second Quarter Earnings
Home Sitemap Contact Us
© businessNewsNewsNews.com